Table 2.
Clinical data of patients used for cellular miRNA analysis.
| Clinical characteristics | HC | ASC | CHB | P value |
|---|---|---|---|---|
| Number of patients | 16 | 16 | 16 | P = NS |
| Sex number (%) | ||||
| Female | 6 | 5 | 6 | |
| Male | 10 | 11 | 10 | P = NS |
| Age (years) | ||||
| Median | 45 | 43 | 42 | |
| Range | 34–65 | 27–64 | 25–62 | P = NS |
| ALT | P = NS (ASC versus HC ) | |||
| Median | 27.43 | 34.38 | 95.36 | P< 0.001 (CHB versus HC) |
| Range | 9–69 | 17–89 | 16–253 | P< 0.001 (CHB versus ASC) |
| AST | P = NS (ASC versus HC) | |||
| Median | 24 | 35.29 | 75.50 | P = 0.028 (CHB versus HC ) |
| Range | 14–34 | 21–84 | 9–327 | P = NS (CHB versus ASC ) |
| HBV DNA | ||||
| Median | NA | 1.51 × 106 | 2.70 × 108 | |
| Range | NA | 2.12 × 103–5.99 × 106 | 2.37 × 104–2.51 × 109 | P = NS (CHB versus ASC) |
| HBsAg | ||||
| HBsAg (+) | NA | 4 (25%) | 10 (62.5%) | |
| HBsAg (−) | NA | 12 (75%) | 6 (37.5%) | P = 0.033 (CHB versus ASC) |